| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |